We are live on ! Find out more
CINC

CinCor Pharma, Inc. Common Stock
CINC

Delisted

CINC was delisted on the 23rd of February, 2023.

Back to rankings

86 hedge funds and large institutions have $1.21B invested in CinCor Pharma, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 38 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

580% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 5

217% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 12

104% more capital invested

Capital invested by funds: $596M → $1.21B (+$617M)

51% more funds holding

Funds holding: 57 → 86 (+29)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

83% less call options, than puts

Call options by funds: $617K | Put options by funds: $3.69M

Holders
86
Holders Change
+29
Holders Change %
+50.88%
% of All Funds
1.48%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
34
Increased
38
Reduced
12
Closed
5
Calls
$617K
Puts
$3.69M
Net Calls
-$3.07M
Net Calls Change
-$3.07M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$27.9M
2
BBA
Baker Bros. Advisors
New York
+$22.8M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$21.6M
4
5VM
5AM Venture Management
California
+$17M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$16.9M

Top Sellers

Rank Fund Capital Flow
1
SCV
Sands Capital Ventures
Virginia
-$17.9M
2
OFM
Omega Fund Management
Massachusetts
-$11.5M
3
GPP
Great Point Partners
Connecticut
-$10.4M
4
BI
BVF Inc
California
-$9.38M
5
VP
venBio Partners
California
-$7.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$459K +$396K +14,000 New
BFM
52
Boothbay Fund Management
New York
$450K +$388K +13,718 New
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$401K +$74.7K +2,642 +28%
CS
54
Credit Suisse
Switzerland
$395K +$52.3K +1,850 +18%
SEI Investments
55
SEI Investments
Pennsylvania
$389K +$335K +11,850 New
BNP Paribas Financial Markets
56
BNP Paribas Financial Markets
France
$389K +$335K +11,849 New
MIM
57
MetLife Investment Management
New Jersey
$376K +$95.2K +3,367 +42%
Bank of America
58
Bank of America
North Carolina
$332K -$459K -16,255 -62%
AIG
59
American International Group
New York
$312K +$91.6K +3,243 +52%
Deutsche Bank
60
Deutsche Bank
Germany
$276K +$77K +2,726 +48%
Walleye Trading
61
Walleye Trading
New York
$270K +$232K +8,226 New
VOYA Investment Management
62
VOYA Investment Management
Georgia
$252K +$217K +7,690 New
Renaissance Technologies
63
Renaissance Technologies
New York
$230K +$198K +7,000 New
State Board of Administration of Florida Retirement System
64
State Board of Administration of Florida Retirement System
Florida
$230K +$198K +7,000 New
Invesco
65
Invesco
Georgia
$227K +$195K +6,907 New
CSS
66
Cubist Systematic Strategies
Connecticut
$207K -$144K -5,100 -45%
Cambridge Investment Research Advisors
67
Cambridge Investment Research Advisors
Iowa
$204K +$176K +6,225 New
Legal & General Group
68
Legal & General Group
United Kingdom
$200K +$50.2K +1,775 +41%
SIM
69
Sandia Investment Management
Massachusetts
$164K +$141K +5,000 New
Osaic Holdings
70
Osaic Holdings
Arizona
$153K -$28 -1 -0%
Barclays
71
Barclays
United Kingdom
$89K +$57.5K +2,036 +303%
SO
72
STRS Ohio
Ohio
$88K – – –
AB
73
Amalgamated Bank
New York
$88K +$16K +567 +27%
Citigroup
74
Citigroup
New York
$84K +$36.1K +1,276 +100%
AIP
75
Ameritas Investment Partners
Nebraska
$51K +$19K +671 +75%
1 2
3
4

CINC Hedge Fund Activity: Q3 2022 in Review

86 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in CinCor Pharma, Inc. Common Stock (CINC) for Q3 2022, worth a combined $1.21B — up 104% from $596M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new CINC positions and 5 closed out — a net gain of 29 holders — while 38 added to existing stakes and 12 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $27.9M. The largest seller was Sands Capital Ventures, exiting entirely with an estimated $17.9M sold.

  • 86 institutional investors held CinCor Pharma, Inc. Common Stock (CINC) as of Q3 2022, up from 57 in Q2 2022.
  • Funds reported $1.21B of CinCor Pharma, Inc. Common Stock stock for Q3 2022, up 104% quarter-over-quarter.
  • 34 funds opened new CinCor Pharma, Inc. Common Stock positions in Q3 2022 and 5 closed out, a net change of +29 holders.
  • The largest CinCor Pharma, Inc. Common Stock buyer in Q3 2022 was Perceptive Advisors, an estimated $27.9M added.
  • The largest CinCor Pharma, Inc. Common Stock seller in Q3 2022 was Sands Capital Ventures, an estimated $17.9M sold.

Based on aggregated 13F filings for Q3 2022.